|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Follicular Lymphoma | |||||
| Diffuse Large Cell Lymphoma | |||||
| Mantle Cell Lymphoma | |||||
| Small Lymphocytic Lymphoma | |||||
| Chronic Lymphocytic Leukemia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Leukemia | |||||
| Leukemia, B-Cell | |||||
| Leukemia, Lymphocytic, Chronic, B-Cell | |||||
| Leukemia, Lymphoid | |||||
| Lymphoma | |||||
| Lymphoma, Follicular | |||||
| Lymphoma, Large B-Cell, Diffuse | |||||
| Lymphoma, Mantle-Cell | |||||
| 3 | More general conditions related to this trial | ||||
| Immune System Diseases | |||||
| Immunoproliferative Disorders | |||||
| Lymphatic Diseases | |||||
| Lymphoma, B-Cell | |||||
| Lymphoma, Non-Hodgkin | |||||
| Lymphoproliferative Disorders | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| 4 | Interventions listed in this trial | ||||
| AT-101 | |||||
| 5 | Sponsors listed in this trial | ||||
| Ascenta Therapeutics | |||||